NME

(redirected from Neisseria meningitidis)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to Neisseria meningitidis: Neisseria gonorrhoeae
AcronymDefinition
NMEName
NMENew Musical Express
NMEEnemy
NMENavy Medicine East (Portsmouth, VA)
NMENightmare Enterprises
NMENippon Marine Enterprises (Japan)
NMENetwork Module Enhanced
NMENew Medium Enterprises
NMENetwork Management Entity
NMENorton Mobile Essentials
NMENetwork Monitoring and Evaluation
NMENormalized Mean Error
NMENew Molecular Entities (US FDA New Drug Approval reports)
NMENew Music Express (English weekly magazine)
NMENational Marriage Encounter (counseling; various locations)
NMENashville Mandolin Ensemble (Nashville, TN)
NMENeisseria Meningitidis
NMENetwork Management Ethernet
NMENational Magazine Exchange
NMENational Military Establishment (original name for the US Defense Department)
NMENew Medium Enterprises Inc.
NMENecrolytic Migratory Erythema
NMENew Miserable Experience (Gin Blossoms album)
NMENightmute AK (airport code)
NMENorwegian Maritime Exporters (Association of)
NMENational Museum of Ethnology (Japan)
NMENew Member Education
NMENon Mission Essential
NMENew Media Enterprises (Ameritech)
NMEAssociation of Norwegian Maritime Exporters (Oslo, Norway)
NMENorton Mobile Essentials (Symantec)
NMENecrotizing Meningoencephalitis
NMENissan Motorsport Europe
NMENetwork Management Equipment (Sprint)
NMEnon-milk extrinsic sugar
NMENoise Measuring Equipment
NMENo Mercy Ever (gaming)
NMENumber of Methods Extended
References in periodicals archive ?
The clinical consequences of Neisseria meningitidis colonization and dissemination through the brain and peripheral microvessels are not only a result of the capacity of the survival and multiplication of meningococci in the bloodstream.
Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.
TRUMENBA (Meningococcal Group B Vaccine) is indicated for active immunization of individuals 10 years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B.
Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenza.
Orogenital transmission of Neisseria meningitidis serogroup C confirmed by genotyping techniques.
The report provides a snapshot of the global therapeutic landscape of Neisseria Meningitidis Infections
This bivalent recombinant LP2086 (rLP2086) vaccine candidate is being reviewed for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in ten through 25 year olds, revealed the company.
situation in the country after detecting neisseria meningitidis cases recently.
Neisseria meningitidis (meningococo), es un diplococo Gram negativo especifico del ser humano, el cual es el unico reservorio conocido hasta la fecha (1, 2).
To the Editor: Neisseria meningitidis is an exclusive human pathogen causing serious disease worldwide resulting in rapid mortality, and is associated with large epidemics every 5-10 years.
Microbiologists who are routinely exposed to isolates of Neisseria meningitidis.